Association of Lipoprotein-Associated Phospholipase A2 with the Prevalence of Nonalcoholic Fatty Liver Disease: A Result from the APAC Study
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Association of Lipoprotein-Associated Phospholipase A2 with the Prevalence of Nonalcoholic Fatty Liver Disease: A Result from the APAC Study
Authors
Keywords
-
Journal
Scientific Reports
Volume 8, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-06-28
DOI
10.1038/s41598-018-28494-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Longitudinal study of circulating oxidized LDL and HDL and fatty liver: the Cardiovascular Risk in Young Finns Study
- (2016) Jari E. Kaikkonen et al. FREE RADICAL RESEARCH
- Non-alcoholic fatty liver disease and dyslipidemia: An update
- (2016) Niki Katsiki et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Lipoprotein-associated phospholipase A2 and risk of incident peripheral arterial disease in a multi-ethnic cohort: The Multi-Ethnic Study of Atherosclerosis
- (2016) Parveen K Garg et al. VASCULAR MEDICINE
- Nonalcoholic fatty liver disease as a potential risk factor of cardiovascular disease
- (2015) Jun Luo et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Oxidative stress promotes pathologic polyploidization in nonalcoholic fatty liver disease
- (2015) Géraldine Gentric et al. JOURNAL OF CLINICAL INVESTIGATION
- Mitochondrial metabolism mediates oxidative stress and inflammation in fatty liver
- (2015) Santhosh Satapati et al. JOURNAL OF CLINICAL INVESTIGATION
- Pathophysiological Role and Clinical Significance of Lipoprotein-Associated Phospholipase A2 (Lp-PLA2) Bound to LDL and HDL
- (2014) Constantinos Tellis et al. CURRENT PHARMACEUTICAL DESIGN
- Are oxidative stress mechanisms the common denominator in the progression from hepatic steatosis towards non-alcoholic steatohepatitis (NASH)?
- (2014) Zoon Tariq et al. LIVER INTERNATIONAL
- Cholesterol-Induced Non-Alcoholic Fatty Liver Disease and Atherosclerosis Aggravated by Systemic Inflammation
- (2014) Eung Ju Kim et al. PLoS One
- Paraoxonase-1 Deficiency Is Associated with Severe Liver Steatosis in Mice Fed a High-fat High-cholesterol Diet: A Metabolomic Approach
- (2013) Anabel García-Heredia et al. JOURNAL OF PROTEOME RESEARCH
- The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
- (2012) Naga Chalasani et al. HEPATOLOGY
- Modulation of oxidative stress, inflammation, and atherosclerosis by lipoprotein-associated phospholipase A2
- (2012) Robert S. Rosenson et al. JOURNAL OF LIPID RESEARCH
- Antioxidant and inflammatory aspects of lipoprotein-associated phospholipase A2 (Lp-PLA2 ): a review
- (2011) Isis T Silva et al. Lipids in Health and Disease
- Association of Serum Lipoprotein-Associated Phospholipase A2 Level with Nonalcoholic Fatty Liver Disease
- (2011) Yasar Colak et al. Metabolic Syndrome and Related Disorders
- Serum platelet-activating factor acetylhydrolase activity: relationship with metabolic syndrome in women with history of gestational diabetes mellitus
- (2010) Aysel Derbent et al. GYNECOLOGICAL ENDOCRINOLOGY
- Guidelines for the diagnosis and management of nonalcoholic fatty liver disease: Update 2010
- (2010) Jian Gao FAN et al. Journal of Digestive Diseases
- Τhe role of lipoprotein-associated phospholipase A2 in atherosclerosis may depend on its lipoprotein carrier in plasma
- (2009) Constantinos C. Tellis et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon?
- (2008) G. Targher et al. DIABETOLOGIA
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started